Xuezhong Gong

7PUBLICATIONS
7CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatmentsPredictive and prognostic markersObstetrics and gynaecologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2026
Association of Chuanhuang Patent Formula with prognosis in patients with acute kidney injury on chronic kidney disease: a retrospective cohort study.

|May 24, 2024
Exploring therapeutic mechanisms of Chuan Huang Fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics.

Ling Chen, Qian Wang, Tonglu Li

|Feb 15, 2024
Tetramethylpyrazine attenuates renal tubular epithelial cell ferroptosis in contrast-induced nephropathy by inhibiting transferrin receptor and intracellular reactive oxygen species.

Zhongqiang Zhu, Jun Li, Zhiyong Song

|Mar 28, 2022
Efficacy and Safety of Chuan Huang Fang Combining Reduced Glutathione in Treating Acute Kidney Injury (Grades 1-2) on Chronic Kidney Disease (Stages 2-4): Study Protocol for a Multicenter Randomized Controlled Clinical Trial.

Ling Chen, Xuezhong Gong

|Dec 13, 2021
Clinical efficacy of Tailin formulation combined with continuous low-dose antimicrobial therapy for recurrent urinary tract infection: study protocol for a multicenter, double-blind, randomized, controlled clinical trial.

Tonglu Li, Yingru Xu, Xuezhong Gong

|Jun 22, 2019
Tetramethylpyrazine Prevents Contrast-Induced Nephropathy via Modulating Tubular Cell Mitophagy and Suppressing Mitochondrial Fragmentation, CCL2/CCR2-Mediated Inflammation, and Intestinal Injury.

Xuezhong Gong, Yiru Duan, Junli Zheng

Pageof 2

Frequent Collaborators

1 joint publications

Yiru Duan

1 joint publications

Ling Chen

1 joint publications

Jun Li

1 joint publications

Yifan Zhang